Treatment of Staphylococcus aureus bacteraemia

BMJ 2006; 333 doi: 10.1136/bmj.333.7564.397-b (Published 17 August 2006)
Cite this as: BMJ 2006;333:397.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Charis Marwick, specialist registrar infectious diseases,
  2. William J Olver, consultant microbiologist (william.olver@nhs.net)
  1. Ninewells Hospital and Medical School, Dundee DD1 9SY
  2. Ninewells Hospital and Medical School, Dundee DD1 9SY

    EDITOR—In his editorial on Staphylococcus aureus bacteraemia Paul says that some doubt remains about the optimal duration of antibiotic treatment.1 A prospective study of 278 cases of S aureus bacteraemia (mainly methicillin sensitive strains) looked at potential risk factors and outcome, using multiple regression analysis.2 Factors related to death …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL